Panagora Asset Management Inc. Buys 11,525 Shares of Maximus, Inc. $MMS

Panagora Asset Management Inc. lifted its stake in shares of Maximus, Inc. (NYSE:MMSFree Report) by 4.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 272,275 shares of the health services provider’s stock after purchasing an additional 11,525 shares during the quarter. Panagora Asset Management Inc. owned 0.50% of Maximus worth $23,503,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Richardson Financial Services Inc. increased its stake in Maximus by 29.6% in the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after acquiring an additional 103 shares during the last quarter. Farther Finance Advisors LLC increased its stake in Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after acquiring an additional 116 shares during the last quarter. Parkside Financial Bank & Trust increased its stake in Maximus by 13.4% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock worth $109,000 after acquiring an additional 150 shares during the last quarter. GAMMA Investing LLC increased its stake in Maximus by 13.8% in the 4th quarter. GAMMA Investing LLC now owns 1,522 shares of the health services provider’s stock worth $131,000 after acquiring an additional 185 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

Shares of NYSE MMS opened at $61.19 on Tuesday. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. The firm has a market capitalization of $3.21 billion, a P/E ratio of 9.16 and a beta of 0.58. The stock’s 50-day simple moving average is $63.44 and its two-hundred day simple moving average is $75.68. Maximus, Inc. has a twelve month low of $56.92 and a twelve month high of $100.00.

Maximus (NYSE:MMSGet Free Report) last announced its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, beating the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company’s revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the company earned $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, equities analysts anticipate that Maximus, Inc. will post 8.43 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a dividend of $0.33 per share. The ex-dividend date was Friday, May 15th. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. Maximus’s dividend payout ratio is 19.76%.

Analyst Ratings Changes

MMS has been the topic of a number of research analyst reports. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Maximus

Maximus Profile

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.